European guideline addresses treatment of aggressive pituitary tumours, carcinomas

Patients with aggressive pituitary tumours and carcinomas should be treated by a multidisciplinary team and receive full endocrine laboratory evaluation and histopathologic analyses for tumour classification, according to recommendations included in new clinical practice guidelines released by the European Society of Endocrinology.